Ascendis Pharma A/S Announces Conference Call and Webcast to Review Data at ENDO 2017 on April 3
COPENHAGEN, Denmark, March 23, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that util... Read More
Ascendis Pharma A/S Reports Full Year 2016 Financial Results
- Company Expanded Pipeline and Initiated Phase 3 Trial for Lead Product Candidate, TransCon Growth Hormone - - Conference... Read More